Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1420537-07-0

Post Buying Request

1420537-07-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1420537-07-0 Usage

General Description

Tert-butyl (3R,4S)-3-(3-fluorophenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate is a chemical compound with a molecular formula of C17H24FNO3. It is a pyrrolidine derivative with a tert-butyl group, a fluorophenyl group, and a hydroxymethyl group attached to the pyrrolidine ring. tert-butyl (3R,4S)-3-(3-fluorophenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate has potential applications in the fields of medicinal chemistry and drug discovery due to its unique structure and properties. Further research may be needed to investigate its potential pharmacological activities and therapeutic uses.

Check Digit Verification of cas no

The CAS Registry Mumber 1420537-07-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,0,5,3 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1420537-07:
(9*1)+(8*4)+(7*2)+(6*0)+(5*5)+(4*3)+(3*7)+(2*0)+(1*7)=120
120 % 10 = 0
So 1420537-07-0 is a valid CAS Registry Number.

1420537-07-0Downstream Products

1420537-07-0Relevant articles and documents

Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety

-

Page/Page column 14, (2008/06/13)

The present invention relates to cis-derivatives of formula wherein R1, R2, and R3 are as defined herein and to pharmaceutically acceptable acid addition salts thereof. The compounds of formula I are good inhibitors of the

Pyrrolidine modulators of CCR5 chemokine receptor activity

-

, (2008/06/13)

Pyrrolidine compounds of Formula I: (wherein 1, R2, R3, R4, R5,R6a, R6b, R7 and R8 are defined herein) are described. The compounds are modulators of CCR5 chemokine receptor activity. The compounds are useful, for example, in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1420537-07-0